speb/financial-data huggingface dataset:
FHI income_statement (annual, 2024-12-31) — Normalized EBITDA: 463396000.00
FHI income_statement (annual, 2024-12-31) — Normalized Income: 301158618.42
FHI cash_flow (annual, 2024-12-31) — Operating Cash Flow: 346554000.00
FHI cash_flow (annual, 2024-12-31) — Operating Gains Losses: -38131000.00
FHI income_statement (annual, 2024-12-31) — Operating Income: 440828000.00
FHI income_statement (annual, 2024-12-31) — Operating Revenue: 1632093000.00
FHI balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 81768679.00
FHI balance_sheet (annual, 2024-12-31) — Other Current Assets: 4796000.00
FHI balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 15418000.00
FHI balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -32083000.00
FHI income_statement (annual, 2024-12-31) — Other Gand A: 170868000.00
FHI income_statement (annual, 2024-12-31) — Other Income Expense: -46554000.00
FHI balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 327881000.00
FHI balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 40358000.00
FHI balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 28542000.00
FHI income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 139000.00
FHI income_statement (annual, 2024-12-31) — Other Operating Expenses: 33548000.00
FHI balance_sheet (annual, 2024-12-31) — Other Properties: 104710000.00
FHI balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 136601000.00
FHI income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 11605000.00
FHI balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 100012000.00
FHI balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 157068000.00
FHI balance_sheet (annual, 2024-12-31) — Prepaid Assets: 29294000.00
FHI income_statement (annual, 2024-12-31) — Pretax Income: 381609000.00
FHI balance_sheet (annual, 2024-12-31) — Properties: 0.00
FHI balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
FHI cash_flow (annual, 2024-12-31) — Purchase Of Business: -47516000.00
FHI cash_flow (annual, 2024-12-31) — Purchase Of PPE: -4024000.00
FHI balance_sheet (annual, 2024-12-31) — Receivables: 106220000.00
FHI income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 540486000.00
FHI income_statement (annual, 2024-12-31) — Reconciled Depreciation: 22429000.00
FHI income_statement (annual, 2024-12-31) — Rent And Landing Fees: 39946000.00
FHI income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 39946000.00
FHI cash_flow (annual, 2024-12-31) — Repayment Of Debt: 0.00
FHI cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -137615000.00
FHI balance_sheet (annual, 2024-12-31) — Retained Earnings: 1256603000.00
FHI cash_flow (annual, 2024-12-31) — Sale Of Business: 119891000.00
FHI income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 406417000.00
FHI income_statement (annual, 2024-12-31) — Selling General And Administration: 617231000.00
FHI balance_sheet (annual, 2024-12-31) — Share Issued: 99514456.00
FHI income_statement (annual, 2024-12-31) — Special Income Charges: -79361000.00
FHI cash_flow (annual, 2024-12-31) — Stock Based Compensation: 28784000.00
FHI balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1095206000.00
FHI balance_sheet (annual, 2024-12-31) — Tangible Book Value: -37493000.00
FHI income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -13848381.58
FHI income_statement (annual, 2024-12-31) — Tax Provision: 113179000.00
FHI income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.30
FHI balance_sheet (annual, 2024-12-31) — Total Assets: 2084684000.00
FHI balance_sheet (annual, 2024-12-31) — Total Capitalization: 1443312000.00
FHI balance_sheet (annual, 2024-12-31) — Total Debt: 461967000.00
FHI balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1150720000.00
FHI income_statement (annual, 2024-12-31) — Total Expenses: 1191265000.00
FHI balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 933964000.00
FHI balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1303332000.00
FHI balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 644771000.00
FHI income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 361467000.00
FHI income_statement (annual, 2024-12-31) — Total Unusual Items: -46693000.00
FHI income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -46693000.00
FHI balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 17745777.00
FHI balance_sheet (annual, 2024-12-31) — Treasury Stock: 632838000.00
FHI cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -3929000.00
FHI balance_sheet (annual, 2024-12-31) — Working Capital: 492159000.00
FHI income_statement (quarterly, 2025-03-31) — +Operating Expense: 145302000.00
FHI income_statement (quarterly, 2025-03-31) — +Total Revenue: 423540000.00
FHI balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 92413000.00
FHI balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 64322000.00
FHI balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -120635000.00
FHI balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -21000.00
FHI income_statement (quarterly, 2025-03-31) — Basic Average Shares: 77541000.00
FHI income_statement (quarterly, 2025-03-31) — Basic EPS: 1.25
FHI cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 507567000.00
FHI cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -972000.00
FHI balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 110926000.00
FHI balance_sheet (quarterly, 2025-03-31) — Capital Stock: 514641000.00
FHI balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 387567000.00
FHI balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 541826000.00
FHI cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -25305000.00
FHI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -137568000.00
FHI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1528000.00
FHI cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 14299000.00
FHI cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 20355000.00
FHI cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -101218000.00
FHI cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 1280000.00
FHI cash_flow (quarterly, 2025-03-31) — Change In Receivables: -10955000.00
FHI cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -90538000.00
FHI cash_flow (quarterly, 2025-03-31) — Changes In Cash: -124797000.00
FHI balance_sheet (quarterly, 2025-03-31) — Common Stock: 514641000.00
FHI cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -25305000.00
FHI balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1076142000.00
FHI cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -120131000.00
FHI income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 143270000.00
FHI balance_sheet (quarterly, 2025-03-31) — Current Assets: 678574000.00
FHI balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 16861000.00
FHI balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 16861000.00
FHI balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 222993000.00
FHI cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 531000.00
FHI cash_flow (quarterly, 2025-03-31) — Deferred Tax: 531000.00
FHI cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5416000.00
FHI cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 5416000.00
FHI income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 77542000.00
FHI income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.25
FHI income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 96622000.00
FHI balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 38689000.00
FHI income_statement (quarterly, 2025-03-31) — EBIT: 139220000.00
FHI income_statement (quarterly, 2025-03-31) — EBITDA: 144636000.00
FHI cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 5266000.00
FHI cash_flow (quarterly, 2025-03-31) — End Cash Position: 388036000.00
FHI cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -137568000.00
FHI cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 13327000.00
FHI cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of Business: -15141000.00
FHI income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 7475000.00
FHI balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -16916000.00
FHI income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 52726000.00
FHI balance_sheet (quarterly, 2025-03-31) — Goodwill: 808911000.00
FHI balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1138833000.00
FHI balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 64343000.00
FHI balance_sheet (quarterly, 2025-03-31) — Gross PPE: 244487000.00
FHI income_statement (quarterly, 2025-03-31) — Gross Profit: 280270000.00
FHI income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 3196000.00
FHI balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 29816000.00
FHI income_statement (quarterly, 2025-03-31) — Interest Expense: 3179000.00
FHI income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 3179000.00
FHI balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1424313000.00
FHI cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1528000.00
FHI balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 94065000.00
FHI balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 348171000.00
FHI balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 442236000.00
FHI balance_sheet (quarterly, 2025-03-31) — Minority Interest: 67190000.00
FHI income_statement (quarterly, 2025-03-31) — Minority Interests: -2742000.00
FHI cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -528000.00
FHI cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -120131000.00
FHI income_statement (quarterly, 2025-03-31) — Net Income: 101134000.00
FHI income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 96622000.00
FHI income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 103876000.00
FHI income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 101134000.00
FHI income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 101134000.00
FHI cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 103876000.00
FHI income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 103876000.00
FHI income_statement (quarterly, 2025-03-31) — Net Interest Income: -3179000.00
FHI income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -3179000.00
FHI cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 7868000.00
FHI cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -28000.00
FHI balance_sheet (quarterly, 2025-03-31) — Net PPE: 123852000.00
FHI cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -972000.00
FHI balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -62691000.00
FHI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 172248000.00
FHI balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 172248000.00
FHI income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 140357000.00
FHI income_statement (quarterly, 2025-03-31) — Normalized Income: 97864844.00
FHI cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 14299000.00
FHI cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -16671000.00
FHI income_statement (quarterly, 2025-03-31) — Operating Income: 134968000.00
FHI income_statement (quarterly, 2025-03-31) — Operating Revenue: 423540000.00
FHI balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 79105157.00
FHI balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2170000.00
FHI balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 14979000.00
FHI balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -16916000.00
FHI income_statement (quarterly, 2025-03-31) — Other Gand A: 42774000.00
FHI income_statement (quarterly, 2025-03-31) — Other Income Expense: 4252000.00
FHI balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 329922000.00
FHI balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 60794000.00
FHI balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 21244000.00
FHI income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -27000.00
FHI income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -11085000.00
FHI balance_sheet (quarterly, 2025-03-31) — Other Properties: 244487000.00
FHI balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 154259000.00
FHI income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 4512000.00
FHI balance_sheet (quarterly, 2025-03-31) — Payables: 122229000.00
FHI balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 122229000.00
FHI balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 68924000.00
FHI balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 31567000.00
FHI income_statement (quarterly, 2025-03-31) — Pretax Income: 136041000.00
FHI cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -1758000.00
FHI cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -972000.00
FHI balance_sheet (quarterly, 2025-03-31) — Receivables: 103011000.00
FHI income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 143270000.00
FHI income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5416000.00
FHI income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 9952000.00
FHI income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 9952000.00
FHI cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -120131000.00
FHI balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1319995000.00
FHI cash_flow (quarterly, 2025-03-31) — Sale Of Business: 1230000.00
FHI income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 103661000.00
FHI income_statement (quarterly, 2025-03-31) — Selling General And Administration: 156387000.00
FHI balance_sheet (quarterly, 2025-03-31) — Share Issued: 99514456.00
FHI income_statement (quarterly, 2025-03-31) — Special Income Charges: -3196000.00
FHI cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 11117000.00
FHI balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1076142000.00
FHI balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -62691000.00
FHI income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 1009844.00
FHI income_statement (quarterly, 2025-03-31) — Tax Provision: 32165000.00
FHI income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.24
FHI balance_sheet (quarterly, 2025-03-31) — Total Assets: 2002053000.00
FHI balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1424313000.00
FHI balance_sheet (quarterly, 2025-03-31) — Total Debt: 459097000.00
FHI balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1143332000.00
FHI income_statement (quarterly, 2025-03-31) — Total Expenses: 288572000.00
FHI balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 858721000.00
FHI balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1323479000.00
FHI balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 635728000.00
FHI income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 131772000.00
FHI balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 29816000.00
FHI income_statement (quarterly, 2025-03-31) — Total Unusual Items: 4279000.00
FHI income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 4279000.00
FHI balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 20409299.00
FHI balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 741578000.00
FHI cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 568000.00
FHI balance_sheet (quarterly, 2025-03-31) — Working Capital: 455581000.00
FHI income_statement (quarterly, 2025-06-30) — +Operating Expense: 159385000.00
FHI income_statement (quarterly, 2025-06-30) — +Total Revenue: 424844000.00
FHI balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 63979000.00
FHI balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -123951000.00
FHI balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 6000.00
FHI balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -21000.00
FHI income_statement (quarterly, 2025-06-30) — Basic Average Shares: 75064000.00
FHI income_statement (quarterly, 2025-06-30) — Basic EPS: 1.16
FHI cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 388036000.00
FHI cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -786000.00
FHI balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 112264000.00
FHI balance_sheet (quarterly, 2025-06-30) — Capital Stock: 521018000.00
FHI balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 370987000.00
FHI balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 607479000.00
FHI cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -26846000.00
FHI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -31693000.00
FHI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -16016000.00
FHI cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 18787000.00
FHI cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -31614000.00
FHI cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 22157000.00
FHI cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -5028000.00
FHI cash_flow (quarterly, 2025-06-30) — Change In Receivables: 5448000.00
FHI cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -9037000.00
FHI cash_flow (quarterly, 2025-06-30) — Changes In Cash: -28922000.00
FHI balance_sheet (quarterly, 2025-06-30) — Common Stock: 521018000.00
FHI cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -26846000.00
FHI balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1114105000.00
FHI cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -65524000.00
FHI income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 144872000.00
FHI balance_sheet (quarterly, 2025-06-30) — Current Assets: 760682000.00
FHI balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 17595000.00
FHI balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 17595000.00
FHI balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 225729000.00
FHI cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -1380000.00
FHI cash_flow (quarterly, 2025-06-30) — Deferred Tax: -1380000.00
FHI cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 5637000.00
FHI cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 5637000.00
FHI income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 75072000.00
FHI income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.16
FHI income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 86857000.00
FHI balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 38476000.00
FHI income_statement (quarterly, 2025-06-30) — EBIT: 133996000.00
FHI income_statement (quarterly, 2025-06-30) — EBITDA: 139633000.00
FHI cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 12356000.00
FHI cash_flow (quarterly, 2025-06-30) — End Cash Position: 371470000.00
FHI cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -31693000.00
FHI cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 18001000.00
FHI cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of Business: -68303000.00
FHI income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 16947000.00
FHI balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 15666000.00
FHI income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 52019000.00
FHI balance_sheet (quarterly, 2025-06-30) — Goodwill: 864764000.00
FHI balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1207039000.00
FHI balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 64000000.00
FHI balance_sheet (quarterly, 2025-06-30) — Gross PPE: 248678000.00
FHI income_statement (quarterly, 2025-06-30) — Gross Profit: 279972000.00
FHI income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 3503000.00
FHI income_statement (quarterly, 2025-06-30) — Interest Expense: 3170000.00
FHI income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 3170000.00
FHI balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1462342000.00
FHI cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -16016000.00
FHI balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 94669000.00
FHI balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 348237000.00
FHI balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 442906000.00
FHI balance_sheet (quarterly, 2025-06-30) — Minority Interest: 162993000.00
FHI income_statement (quarterly, 2025-06-30) — Minority Interests: -5691000.00
FHI cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -9230000.00
FHI cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -65524000.00
FHI income_statement (quarterly, 2025-06-30) — Net Income: 91000000.00
FHI income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 86857000.00
FHI income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 96691000.00
FHI income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 91000000.00
FHI income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 91000000.00
FHI cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 96691000.00
FHI income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 96691000.00
FHI income_statement (quarterly, 2025-06-30) — Net Interest Income: -3170000.00
FHI income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -3170000.00
FHI cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 60677000.00
FHI cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -6000000.00
FHI balance_sheet (quarterly, 2025-06-30) — Net PPE: 124727000.00
FHI cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -786000.00
FHI balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -92934000.00
FHI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 172395000.00
FHI balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 172395000.00
FHI income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 126189000.00
FHI income_statement (quarterly, 2025-06-30) — Normalized Income: 81064884.00
FHI cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 18787000.00
FHI cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -70005000.00
FHI income_statement (quarterly, 2025-06-30) — Operating Income: 120587000.00
FHI income_statement (quarterly, 2025-06-30) — Operating Revenue: 424844000.00
FHI balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 77567675.00
FHI balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 15927000.00
FHI balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 17918000.00
FHI balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 15666000.00
FHI income_statement (quarterly, 2025-06-30) — Other Gand A: 42109000.00
FHI income_statement (quarterly, 2025-06-30) — Other Income Expense: 13409000.00
FHI balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 342275000.00
FHI balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 59137000.00
FHI balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 33457000.00
FHI income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -35000.00
FHI income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1821000.00
FHI balance_sheet (quarterly, 2025-06-30) — Other Properties: 248678000.00
FHI balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 236492000.00
FHI income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 4143000.00
FHI balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 88261000.00
FHI balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 101955000.00
FHI balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 34821000.00
FHI income_statement (quarterly, 2025-06-30) — Pretax Income: 130826000.00
FHI cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -980000.00
FHI cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -786000.00
FHI balance_sheet (quarterly, 2025-06-30) — Receivables: 102455000.00
FHI income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 144872000.00
FHI income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 5637000.00
FHI income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 9910000.00
FHI income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 9910000.00
FHI cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -65524000.00
FHI balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1384017000.00
FHI cash_flow (quarterly, 2025-06-30) — Sale Of Business: 4505000.00
FHI income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 105545000.00
FHI income_statement (quarterly, 2025-06-30) — Selling General And Administration: 157564000.00
FHI balance_sheet (quarterly, 2025-06-30) — Share Issued: 99514456.00
FHI income_statement (quarterly, 2025-06-30) — Special Income Charges: -3503000.00
FHI cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 6392000.00
FHI balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1114105000.00
FHI balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -92934000.00
FHI income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 3508884.00
FHI income_statement (quarterly, 2025-06-30) — Tax Provision: 34135000.00
FHI income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.26
FHI balance_sheet (quarterly, 2025-06-30) — Total Assets: 2151585000.00
FHI balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1462342000.00
FHI balance_sheet (quarterly, 2025-06-30) — Total Debt: 460501000.00
FHI balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1277098000.00
FHI income_statement (quarterly, 2025-06-30) — Total Expenses: 304257000.00
FHI balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 874487000.00
FHI balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1390903000.00
FHI balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 648758000.00
FHI income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 117084000.00
FHI income_statement (quarterly, 2025-06-30) — Total Unusual Items: 13444000.00
FHI income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 13444000.00
FHI balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 21946781.00
FHI balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 806602000.00
FHI cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -9511000.00
FHI balance_sheet (quarterly, 2025-06-30) — Working Capital: 534953000.00
FHI income_statement (quarterly, 2025-09-30) — +Operating Expense: 191875000.00
FHI income_statement (quarterly, 2025-09-30) — +Total Revenue: 469446000.00
FHI balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 59975000.00
FHI balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -101676000.00
FHI balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 6000.00
FHI balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -21000.00
FHI cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
FHI income_statement (quarterly, 2025-09-30) — Basic Average Shares: 74057000.00
FHI income_statement (quarterly, 2025-09-30) — Basic EPS: 1.34
FHI cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 371470000.00
FHI cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1430000.00
FHI balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 112549000.00
FHI balance_sheet (quarterly, 2025-09-30) — Capital Stock: 526674000.00
FHI balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 506279000.00
FHI balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 647391000.00
FHI cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -26365000.00
FHI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 29864000.00
FHI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 5450000.00
FHI cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 103059000.00
FHI cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 42006000.00
FHI cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 38050000.00
FHI cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -35664000.00
FHI cash_flow (quarterly, 2025-09-30) — Change In Receivables: -2965000.00
FHI cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 41427000.00
FHI cash_flow (quarterly, 2025-09-30) — Changes In Cash: 138373000.00
FHI balance_sheet (quarterly, 2025-09-30) — Common Stock: 526674000.00
FHI cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -26365000.00
FHI balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1187286000.00
FHI cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -21000.00
FHI income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 144563000.00
FHI balance_sheet (quarterly, 2025-09-30) — Current Assets: 802336000.00
FHI balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 18157000.00
FHI balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 18157000.00
FHI balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 256400000.00
FHI cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 20797000.00
FHI cash_flow (quarterly, 2025-09-30) — Deferred Tax: 20797000.00
FHI cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5633000.00
FHI cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5633000.00
FHI income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 74057000.00
FHI income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.34
FHI income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 99448000.00
FHI balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 42445000.00
FHI income_statement (quarterly, 2025-09-30) — EBIT: 143509000.00
FHI income_statement (quarterly, 2025-09-30) — EBITDA: 149142000.00
FHI cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -3072000.00
FHI cash_flow (quarterly, 2025-09-30) — End Cash Position: 506771000.00
FHI cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 29864000.00
FHI cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 101629000.00
FHI cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: -68930000.00
FHI income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 14105000.00
FHI balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 5413000.00
FHI income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 56391000.00
FHI balance_sheet (quarterly, 2025-09-30) — Goodwill: 860950000.00
FHI balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1195992000.00
FHI balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 59996000.00
FHI balance_sheet (quarterly, 2025-09-30) — Gross PPE: 230715000.00
FHI income_statement (quarterly, 2025-09-30) — Gross Profit: 324883000.00
FHI income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 3556000.00
FHI income_statement (quarterly, 2025-09-30) — Interest Expense: 3182000.00
FHI income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 3182000.00
FHI balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1535589000.00
FHI cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 5450000.00
FHI balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 94392000.00
FHI balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 348303000.00
FHI balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 442695000.00
FHI balance_sheet (quarterly, 2025-09-30) — Minority Interest: 63515000.00
FHI income_statement (quarterly, 2025-09-30) — Minority Interests: -1969000.00
FHI cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 6880000.00
FHI cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -21000.00
FHI income_statement (quarterly, 2025-09-30) — Net Income: 104126000.00
FHI income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 99448000.00
FHI income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 106095000.00
FHI income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 104126000.00
FHI income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 104126000.00
FHI cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 106095000.00
FHI income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 106095000.00
FHI income_statement (quarterly, 2025-09-30) — Net Interest Income: -3182000.00
FHI income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -3182000.00
FHI cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 56250000.00
FHI cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
FHI balance_sheet (quarterly, 2025-09-30) — Net PPE: 129039000.00
FHI cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1430000.00
FHI balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -8706000.00
FHI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 192671000.00
FHI balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 192671000.00
FHI income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 138593000.00
FHI income_statement (quarterly, 2025-09-30) — Normalized Income: 96150956.00
FHI cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 103059000.00
FHI cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -71775000.00
FHI income_statement (quarterly, 2025-09-30) — Operating Income: 133008000.00
FHI income_statement (quarterly, 2025-09-30) — Operating Revenue: 469446000.00
FHI balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 77546867.00
FHI balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 11490000.00
FHI balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 10494000.00
FHI balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 5413000.00
FHI income_statement (quarterly, 2025-09-30) — Other Gand A: 46262000.00
FHI income_statement (quarterly, 2025-09-30) — Other Income Expense: 10501000.00
FHI balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 335042000.00
FHI balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 54903000.00
FHI balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 39703000.00
FHI income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -48000.00
FHI income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 16651000.00
FHI balance_sheet (quarterly, 2025-09-30) — Other Properties: 230715000.00
FHI balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 141112000.00
FHI income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 4678000.00
FHI balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 91415000.00
FHI balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 136334000.00
FHI balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 41035000.00
FHI income_statement (quarterly, 2025-09-30) — Pretax Income: 140327000.00
FHI cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -2870000.00
FHI cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1430000.00
FHI balance_sheet (quarterly, 2025-09-30) — Receivables: 102420000.00
FHI income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 144563000.00
FHI income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5633000.00
FHI income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 10129000.00
FHI income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 10129000.00
FHI cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -21000.00
FHI balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1461790000.00
FHI cash_flow (quarterly, 2025-09-30) — Sale Of Business: 9750000.00
FHI income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 118833000.00
FHI income_statement (quarterly, 2025-09-30) — Selling General And Administration: 175224000.00
FHI balance_sheet (quarterly, 2025-09-30) — Share Issued: 99514456.00
FHI income_statement (quarterly, 2025-09-30) — Special Income Charges: -3556000.00
FHI cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 5669000.00
FHI balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1187286000.00
FHI balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -8706000.00
FHI income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 2573956.00
FHI income_statement (quarterly, 2025-09-30) — Tax Provision: 34232000.00
FHI income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
FHI balance_sheet (quarterly, 2025-09-30) — Total Assets: 2182270000.00
FHI balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1535589000.00
FHI balance_sheet (quarterly, 2025-09-30) — Total Debt: 460852000.00
FHI balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1250801000.00
FHI income_statement (quarterly, 2025-09-30) — Total Expenses: 336438000.00
FHI balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 931469000.00
FHI balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1379934000.00
FHI balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 675069000.00
FHI income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 129452000.00
FHI income_statement (quarterly, 2025-09-30) — Total Unusual Items: 10549000.00
FHI income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 10549000.00
FHI balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 21967589.00
FHI balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 806597000.00
FHI cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -4787000.00
FHI balance_sheet (quarterly, 2025-09-30) — Working Capital: 545936000.00
FHI income_statement (annual, 2025-12-31) — +Operating Expense: 695364000.00
FHI income_statement (quarterly, 2025-12-31) — +Operating Expense: 198802000.00
FHI income_statement (annual, 2025-12-31) — +Total Revenue: 1800663000.00
FHI income_statement (quarterly, 2025-12-31) — +Total Revenue: 482833000.00
FHI balance_sheet (annual, 2025-12-31) — Accounts Receivable: 47553000.00
FHI balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 47553000.00
FHI balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -86955000.00
FHI balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -86955000.00
FHI balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -21000.00
FHI balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -21000.00
FHI cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
FHI cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
FHI income_statement (annual, 2025-12-31) — Basic Average Shares: 75101000.00
FHI income_statement (quarterly, 2025-12-31) — Basic Average Shares: 73795000.00
FHI income_statement (annual, 2025-12-31) — Basic EPS: 5.13
FHI income_statement (quarterly, 2025-12-31) — Basic EPS: 1.39
FHI cash_flow (annual, 2025-12-31) — Beginning Cash Position: 507567000.00
FHI cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 506771000.00
FHI cash_flow (annual, 2025-12-31) — Capital Expenditure: -2762000.00
FHI balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 108638000.00
FHI balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 108638000.00
FHI balance_sheet (annual, 2025-12-31) — Capital Stock: 532602000.00
FHI balance_sheet (quarterly, 2025-12-31) — Capital Stock: 532602000.00
FHI balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 582542000.00
FHI balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 582542000.00
FHI balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 724297000.00
FHI balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 724297000.00
FHI cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -104872000.00
FHI cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -26356000.00
FHI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -237883000.00
FHI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -98486000.00
FHI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2006000.00
FHI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 14100000.00
FHI cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 297345000.00
FHI cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 161200000.00
FHI cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 4981000.00
FHI cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -25766000.00
FHI cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 5929000.00
FHI cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 46940000.00
FHI cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -18298000.00
FHI cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 21114000.00
FHI cash_flow (annual, 2025-12-31) — Change In Receivables: 4025000.00
FHI cash_flow (quarterly, 2025-12-31) — Change In Receivables: 12497000.00
FHI cash_flow (annual, 2025-12-31) — Change In Working Capital: -3363000.00
FHI cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 54785000.00
FHI cash_flow (annual, 2025-12-31) — Changes In Cash: 61468000.00
FHI cash_flow (quarterly, 2025-12-31) — Changes In Cash: 76814000.00
FHI balance_sheet (annual, 2025-12-31) — Common Stock: 532602000.00
FHI balance_sheet (quarterly, 2025-12-31) — Common Stock: 532602000.00
FHI cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -104872000.00
FHI cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -26356000.00
FHI balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1196948000.00
FHI balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1196948000.00
FHI cash_flow (annual, 2025-12-31) — Common Stock Payments: -262775000.00
FHI cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -77099000.00
FHI income_statement (annual, 2025-12-31) — Cost Of Revenue: 577686000.00
FHI income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 144981000.00
FHI balance_sheet (annual, 2025-12-31) — Current Assets: 863792000.00
FHI balance_sheet (quarterly, 2025-12-31) — Current Assets: 863792000.00
FHI balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 20147000.00
FHI balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 20147000.00
FHI balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 20147000.00
FHI balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 20147000.00
FHI balance_sheet (annual, 2025-12-31) — Current Liabilities: 314141000.00
FHI balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 314141000.00
FHI cash_flow (annual, 2025-12-31) — Deferred Income Tax: 10769000.00
FHI cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -9179000.00
FHI cash_flow (annual, 2025-12-31) — Deferred Tax: 10769000.00
FHI cash_flow (quarterly, 2025-12-31) — Deferred Tax: -9179000.00
FHI cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 22260000.00
FHI cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5574000.00
FHI cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 22260000.00
FHI cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5574000.00
FHI income_statement (annual, 2025-12-31) — Diluted Average Shares: 75103000.00
FHI income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 73795000.00
FHI income_statement (annual, 2025-12-31) — Diluted EPS: 5.13
FHI income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.39
FHI income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 385159000.00
FHI income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 102240000.00
FHI balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 42225000.00
FHI balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 42225000.00
FHI income_statement (annual, 2025-12-31) — EBIT: 560258000.00
FHI income_statement (quarterly, 2025-12-31) — EBIT: 143533000.00
FHI income_statement (annual, 2025-12-31) — EBITDA: 582518000.00
FHI income_statement (quarterly, 2025-12-31) — EBITDA: 149107000.00
FHI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 15346000.00
FHI cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 796000.00
FHI cash_flow (annual, 2025-12-31) — End Cash Position: 584381000.00
FHI cash_flow (quarterly, 2025-12-31) — End Cash Position: 584381000.00
FHI cash_flow (annual, 2025-12-31) — Financing Cash Flow: -237883000.00
FHI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -98486000.00
FHI cash_flow (annual, 2025-12-31) — Free Cash Flow: 294583000.00
FHI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 161626000.00
FHI cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -154452000.00
FHI cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: -2078000.00
FHI income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 46412000.00
FHI income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 7885000.00
FHI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 6484000.00
FHI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 6484000.00
FHI income_statement (annual, 2025-12-31) — General And Administrative Expense: 218958000.00
FHI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 57822000.00
FHI balance_sheet (annual, 2025-12-31) — Goodwill: 852102000.00
FHI balance_sheet (quarterly, 2025-12-31) — Goodwill: 852102000.00
FHI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1183612000.00
FHI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1183612000.00